cAMP/protein kinase A signalling pathway and adrenocortical adenomas

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)
149 Downloads (Pure)


Multiple elements of the cAMP/protein kinase A (PKA) pathway have been shown to be mutated or deregulated in various endocrine disorders, indicating a major role of this pathway in the regulation of hormone secretion and also in tumorigenesis of endocrine cells. In particular, several alterations are known to be involved in the pathogenesis of adrenocortical adenomas associated with autonomous cortisol secretion. 

In this review, recent findings on cAMP/PKA alterations causative for the pathogenesis of benign unilateral cortisol-producing adrenocortical adenomas are summarized. Special emphasis is given to latest reports on newly identified mutations in genes encoding PKA catalytic subunits and their functional characterization.

Original languageEnglish
Pages (from-to)15-21
Number of pages7
JournalCurrent Opinion in Endocrine and Metabolic Research
Early online date21 Jun 2019
Publication statusPublished - 1 Oct 2019


  • adrenal
  • cAMP
  • PKA
  • pathogenesis
  • therapy

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism


Dive into the research topics of 'cAMP/protein kinase A signalling pathway and adrenocortical adenomas'. Together they form a unique fingerprint.

Cite this